NCT04017767

Brief Summary

The purpose of this study is to learn about the effect of sleep apnea and low oxygen on muscle strength and lung function in people with chronic spinal cord injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 9, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 12, 2019

Completed
2 years until next milestone

Study Start

First participant enrolled

July 16, 2021

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

September 8, 2025

Status Verified

September 1, 2025

Enrollment Period

4 years

First QC Date

July 9, 2019

Last Update Submit

September 4, 2025

Conditions

Keywords

NeuroplasticityRespiratory FunctionMotor Function

Outcome Measures

Primary Outcomes (2)

  • The difference in Motor Function assessed via hand grip strength measured by maximum grip strength (MGS) between participants with moderate to severe OSA and without OSA.

    Participants will be instructed to squeeze the hand grip dynamometer with maximal effort for 3-5 seconds. This will be repeated three times for each hand with 1 minute of rest between trials. The highest value obtained will be used as the MGS.

    Baseline

  • The difference in Motor Function assessed via hand grip strength measured by electromyographic (EMG) recordings between participants with moderate to severe OSA and without OSA.

    Electrodes will be secured on the participant to measure EMG. Participants will then be asked to press the index finger against a custom lever. The participant will perform three brief maximal voluntary contractions (MVC) for 3-5 seconds separated by 60 seconds of rest. The highest of the three values will be used.

    Baseline

Secondary Outcomes (3)

  • Change in Motor Function assessed via hand grip strength measured by MGS.

    Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17

  • Change in Motor Function assessed via hand grip strength measured by EMG recordings.

    Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17

  • Change in biomarker levels

    Baseline to Day 1 post AIH, Baseline to Day 3 post AIH, Baseline to Day 10, Baseline to Day 17

Study Arms (2)

Moderate to Severe Obstructive Sleep Apnea (OSA)

EXPERIMENTAL

Individuals with moderate to severe OSA defined as having an Apnea-hypopnea Index (AHI) that is greater than or equal to 15.

Procedure: Induced Acute Intermittent Hypoxia (AIH)Device: AIH mask

Without OSA

ACTIVE COMPARATOR

Individuals without OSA defined as having AHI less than 5.

Procedure: Induced Acute Intermittent Hypoxia (AIH)Device: AIH mask

Interventions

AIH will be administered on days 1-3. Each day entails 15 and 90 second hypoxic intervals (Fraction of Inspired Oxygen (FIO2) = 0.09) alternating with 60-second normoxic intervals (FIO2 = 0.21).

Moderate to Severe Obstructive Sleep Apnea (OSA)Without OSA
AIH maskDEVICE

Induced Intermitted hypoxia will be delivered via the AIH mask. The mask has two one-way valves restricting inspiration to the top valve and expiration to the bottom valve. Hypoxic and normoxic gas mixtures will be delivered through the top valve.

Moderate to Severe Obstructive Sleep Apnea (OSA)Without OSA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 or older,
  • Chronic (≥ 1-year post-injury), non-progressive SCI,
  • Asia Impairment Scale (AIS) C or D,
  • Resting Saturated oxygen (SaO2) ≥ 95%,
  • Cervical injury (C5-C8)

You may not qualify if:

  • Currently hospitalized,
  • Resting heart rate ≥120 Beats per minute (BPM),
  • Resting systolic blood pressure \>180 mmHg,
  • Resting diastolic Blood Pressure \>100 mmHg,
  • Self-reported history of unstable angina or myocardial infarction within the previous month,
  • OSA that is being treated with positive airway pressure therapy,
  • Women who know or suspect they may be pregnant or who may become pregnant,
  • Known underlying lung disease,
  • Pregnant Women,
  • Prisoners,
  • Unable to consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Miami

Miami, Florida, 33136, United States

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveSpinal Cord InjuriesHypoxiaRespiratory Aspiration

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and InjuriesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsPathologic Processes

Study Officials

  • Shirin Shafazand, MD

    University of Miami

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: subjects with OSA compared to subjects without OSA based on their response to IH (intermittent hypoxia) exposure
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 9, 2019

First Posted

July 12, 2019

Study Start

July 16, 2021

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

September 8, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations